SRN Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$818K Buy
2,967
+174
+6% +$47.3K 0.75% 56
2025
Q1
$741K Sell
2,793
-87
-3% -$21.5K 0.83% 59
2024
Q4
$669K Sell
2,880
-639
-18% -$147K 0.59% 92
2024
Q3
$776K Sell
3,519
-147
-4% -$30.4K 0.69% 77
2024
Q2
$721K Hold
3,666
0.6% 85
2024
Q1
$789K Buy
3,666
+174
+5% +$36.6K 0.62% 89
2023
Q4
$735K Buy
+3,492
New +$745K 0.66% 88
2021
Q3
Sell
-16,678
Closed -$3.55M 86
2021
Q2
$3.55M Buy
16,678
+1,228
+8% +$259K 1.21% 47
2021
Q1
$3.16M Buy
15,450
+4,732
+44% +$932K 1.13% 50
2020
Q4
$1.91M Buy
+10,718
New +$1.82M 0.94% 48

Other funds holding CME

SRN Advisors's CME Position: Q2 2025 in Review

SRN Advisors increased its CME Group (CME) stake by 6.2% in Q2 2025, buying an estimated $47.3K and bringing the position to 2,967 shares worth $818K. The position accounts for 0.75% of the portfolio, ranked #56.

SRN Advisors first reported a position in CME in Q4 2020 and has held it in 10 quarters since. The position peaked at $3.55M in Q2 2021. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

  • SRN Advisors held 2,967 shares of CME Group worth $818K as of Q2 2025.
  • SRN Advisors bought 174 CME Group shares in Q2 2025, an estimated $47.3K.
  • CME Group made up 0.75% of SRN Advisors's portfolio in Q2 2025, its #56 holding.
  • SRN Advisors first reported a position in CME Group in Q4 2020 and has held it in 10 quarters since.
  • SRN Advisors's CME Group position peaked at $3.55M in Q2 2021.
  • 1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on SRN Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.